675 related articles for article (PubMed ID: 31861113)
1. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
Layek B; Singh J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
[TBL] [Abstract][Full Text] [Related]
2. Relevance of Nanotechnology in Solving Oral Drug Delivery Challenges: A Perspective Review.
Dhadde SB; Patil JS; Chandakavathe BN; Thippeswamy BS; Kavatekar MG
Crit Rev Ther Drug Carrier Syst; 2020; 37(5):407-434. PubMed ID: 33389846
[TBL] [Abstract][Full Text] [Related]
3. Dosage form designs for the controlled drug release of solid dispersions.
Tran PHL; Tran TTD
Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections.
Gondil VS; Dube T; Panda JJ; Yennamalli RM; Harjai K; Chhibber S
Int J Pharm; 2020 Jan; 573():118850. PubMed ID: 31759993
[TBL] [Abstract][Full Text] [Related]
5. The Brief Analysis of Peptide-combined Nanoparticle: Nanomedicine's Unique Value.
Wang J; Wu J; Li Y; Wen J; Cai J; Tang T; Hu X; Xiang D
Curr Protein Pept Sci; 2020; 21(4):334-343. PubMed ID: 32039679
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
7. Recent developments of nanoparticle-delivered dosage forms for buccal delivery.
Tran PHL; Duan W; Tran TTD
Int J Pharm; 2019 Nov; 571():118697. PubMed ID: 31526839
[TBL] [Abstract][Full Text] [Related]
8. Advantages of nanotechnology-based Chinese herb drugs on biological activities.
Huang S; Chang WH
Curr Drug Metab; 2009 Oct; 10(8):905-13. PubMed ID: 20214585
[TBL] [Abstract][Full Text] [Related]
9. A bird's eye view of nanoparticles prepared by electrospraying: advancements in drug delivery field.
Pawar A; Thakkar S; Misra M
J Control Release; 2018 Sep; 286():179-200. PubMed ID: 30053427
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release from nanocarriers: a review.
Natarajan JV; Nugraha C; Ng XW; Venkatraman S
J Control Release; 2014 Nov; 193():122-38. PubMed ID: 24862321
[TBL] [Abstract][Full Text] [Related]
12. Functionalized gold nanoparticles for drug delivery.
Han G; Ghosh P; Rotello VM
Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
[TBL] [Abstract][Full Text] [Related]
13. Polysaccharide Submicrocarrier for Improved Pulmonary Delivery of Poorly Soluble Anti-infective Ciprofloxacin: Preparation, Characterization, and Influence of Size on Cellular Uptake.
Ho DK; Costa A; De Rossi C; de Souza Carvalho-Wodarz C; Loretz B; Lehr CM
Mol Pharm; 2018 Mar; 15(3):1081-1096. PubMed ID: 29425049
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
[TBL] [Abstract][Full Text] [Related]
15. Development of New Bexarotene-loaded Mesoporous Silica Systems for Topical Pharmaceutical Formulations.
Vasile A; Ignat M; Zaltariov MF; Sacarescu L; Stoleriu I; Draganescu D; Dumitras M; Ochiuz L
Acta Chim Slov; 2018 Mar; 65(1):97-107. PubMed ID: 29562115
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity.
Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F
Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056
[TBL] [Abstract][Full Text] [Related]
17. Design of Zein Conjugation and Surface Modification for Targeting Drug Delivery.
Tran PH; Tran TT
Curr Drug Targets; 2020; 21(4):406-415. PubMed ID: 31518220
[TBL] [Abstract][Full Text] [Related]
18. Development of porous silicon nanocarriers for parenteral peptide delivery.
Kovalainen M; Mönkäre J; Kaasalainen M; Riikonen J; Lehto VP; Salonen J; Herzig KH; Järvinen K
Mol Pharm; 2013 Jan; 10(1):353-9. PubMed ID: 23186283
[TBL] [Abstract][Full Text] [Related]
19. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel.
Ruiz-Gatón L; Espuelas S; Larrañeta E; Reviakine I; Yate LA; Irache JM
Eur J Pharm Sci; 2018 Jun; 118():165-175. PubMed ID: 29597043
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
Rajpoot K
Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
